{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:38:01Z","timestamp":1768549081809,"version":"3.49.0"},"reference-count":55,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T00:00:00Z","timestamp":1509580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"DOI":"10.1210\/js.2017-00323","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T19:57:35Z","timestamp":1509652655000},"page":"1417-1427","source":"Crossref","is-referenced-by-count":24,"title":["Metabolic Concomitants of Obese and Nonobese Women With Features of Polycystic Ovarian Syndrome"],"prefix":"10.1210","volume":"1","author":[{"given":"Jocelyne Matar","family":"Boumosleh","sequence":"first","affiliation":[{"name":"The Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M","family":"Grundy","sequence":"additional","affiliation":[{"name":"The Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390"},{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390"},{"name":"Veterans Affairs Medical Center, Dallas, Texas 75216"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Phan","sequence":"additional","affiliation":[{"name":"The Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian J","family":"Neeland","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria Lena","family":"Vega","sequence":"additional","affiliation":[{"name":"The Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390"},{"name":"Department of Clinical Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390"},{"name":"Veterans Affairs Medical Center, Dallas, Texas 75216"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2017,11,2]]},"reference":[{"issue":"2","key":"2019041121452229800_B1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"2019041121452229800_B2","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019041121452229800_B3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3109\/09513590903015528","article-title":"Central-to-peripheral fat ratio, but not peripheral body fat, is related to insulin resistance and androgen markers in polycystic ovary syndrome","volume":"25","author":"Godoy-Matos","year":"2009","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"2019041121452229800_B4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.fertnstert.2015.05.013","article-title":"Android fat distribution affects some hemostatic parameters in women with polycystic ovary syndrome compared with healthy control subjects matched for age and body mass index","volume":"104","author":"de Mendon\u00e7a-Louzeiro","year":"2015","journal-title":"Fertil Steril"},{"issue":"1","key":"2019041121452229800_B5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-9378(83)90091-1","article-title":"Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features","volume":"147","author":"Barbieri","year":"1983","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2019041121452229800_B6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2019041121452229800_B7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"issue":"6","key":"2019041121452229800_B8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/cen.12830","article-title":"The association between polycystic ovary syndrome (PCOS) and metabolic syndrome: a statistical modelling approach","volume":"83","author":"Ranasinha","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2019041121452229800_B9","first-page":"545","article-title":"Metabolic consequences of polycystic ovary syndrome","volume":"67","author":"Churchill","year":"2015","journal-title":"Minerva Ginecol"},{"issue":"1","key":"2019041121452229800_B10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"issue":"11","key":"2019041121452229800_B11","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1210\/jc.2006-0814","article-title":"Influence of body fat content and distribution on variation in metabolic risk","volume":"91","author":"Vega","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041121452229800_B12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2265.2010.03907.x","article-title":"Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas Heart Study","volume":"74","author":"Chang","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2019041121452229800_B13","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.amjcard.2004.02.058","article-title":"The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health","volume":"93","author":"Victor","year":"2004","journal-title":"Am J Cardiol"},{"issue":"6","key":"2019041121452229800_B14","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1148\/rg.236025115","article-title":"MR imaging of disorders associated with female infertility: use in diagnosis, treatment, and management","volume":"23","author":"Imaoka","year":"2003","journal-title":"Radiographics"},{"issue":"5","key":"2019041121452229800_B15","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00330-009-1643-8","article-title":"Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging","volume":"20","author":"Barber","year":"2010","journal-title":"Eur Radiol"},{"issue":"2","key":"2019041121452229800_B16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1148\/radiology.160.2.3726121","article-title":"Polycystic ovaries: MR imaging","volume":"160","author":"Mitchell","year":"1986","journal-title":"Radiology"},{"key":"2019041121452229800_B17","volume-title":"Contemporary Diagnosis and Management of Obesity and the Metabolic Syndrome","author":"Bray","year":"2003","edition":"3rd ed"},{"key":"2019041121452229800_B18","first-page":"1","article-title":"Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee","volume":"854","author":"World Health Organization","year":"1995","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"2","key":"2019041121452229800_B19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/ajcn\/65.2.403","article-title":"Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice","volume":"65","author":"Abate","year":"1997","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"2019041121452229800_B20","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"2019041121452229800_B21","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"issue":"10","key":"2019041121452229800_B22","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00125-011-2252-z","article-title":"Adipose tissue mass and location affect circulating adiponectin levels","volume":"54","author":"Turer","year":"2011","journal-title":"Diabetologia"},{"issue":"1","key":"2019041121452229800_B23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019041121452229800_B24","first-page":"2841","article-title":"The prevalence of polycystic ovary syndrome in reproductive aged women of different ethnicity: a systematic review and meta-analysis","volume":"31","author":"Ding","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"2019041121452229800_B25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1477-7827-12-89","article-title":"The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in southwest of Iran","volume":"12","author":"Tehrani","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"issue":"7","key":"2019041121452229800_B26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-2007-1009245","article-title":"Anthropometric variables and metabolism in polycystic ovarian disease","volume":"21","author":"Rebuff\u00e9-Scrive","year":"1989","journal-title":"Horm Metab Res"},{"issue":"6","key":"2019041121452229800_B27","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lim","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"3","key":"2019041121452229800_B28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.21727","article-title":"Metabolic correlates of nonalcoholic fatty liver in women and men","volume":"46","author":"Vega","year":"2007","journal-title":"Hepatology"},{"issue":"11","key":"2019041121452229800_B29","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/aogs.12964","article-title":"Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls","volume":"95","author":"Glintborg","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"11","key":"2019041121452229800_B30","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1210\/jc.2016-2586","article-title":"Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women","volume":"101","author":"Dumesic","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041121452229800_B31","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"issue":"1","key":"2019041121452229800_B32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12958-016-0203-8","article-title":"Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis","volume":"14","author":"Yang","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"2019041121452229800_B33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12958-016-0173-x","article-title":"Genetic, hormonal and metabolic aspects of PCOS: an update","volume":"14","author":"De Leo","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"2019041121452229800_B34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.0.1380269","article-title":"Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome","volume":"138","author":"Diamanti-Kandarakis","year":"1998","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2019041121452229800_B35","first-page":"4075","article-title":"Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens","volume":"82","author":"Nestler","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041121452229800_B36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.fertnstert.2003.05.020","article-title":"Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome","volume":"81","author":"Genazzani","year":"2004","journal-title":"Fertil Steril"},{"issue":"6","key":"2019041121452229800_B37","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0015-0282(00)00501-X","article-title":"Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome","volume":"73","author":"Kolodziejczyk","year":"2000","journal-title":"Fertil Steril"},{"issue":"3","key":"2019041121452229800_B38","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0015-0282(01)01975-6","article-title":"Metformin directly inhibits androgen production in human thecal cells","volume":"76","author":"Attia","year":"2001","journal-title":"Fertil Steril"},{"issue":"2","key":"2019041121452229800_B39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/humrep\/dew329","article-title":"Overweight and high-BMI but not normal weight women with PCOS are at increased risk of type 2 diabetes mellitus\u2014a prospective, population-based cohort study","volume":"32","author":"Ollila","year":"2017","journal-title":"Hum Reprod"},{"issue":"3","key":"2019041121452229800_B40","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1210\/jc.2013-2007","article-title":"Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome","volume":"99","author":"Joham","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041121452229800_B41","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-61-5-946","article-title":"Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome","volume":"61","author":"Wild","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2019041121452229800_B42","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/oxfordjournals.humrep.a019505","article-title":"Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies?","volume":"11","author":"Meirow","year":"1996","journal-title":"Hum Reprod"},{"issue":"5","key":"2019041121452229800_B43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0895-4356(98)00010-9","article-title":"Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study","volume":"51","author":"Talbott","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2019041121452229800_B44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejogrb.2013.11.011","article-title":"Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors","volume":"173","author":"Shi","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"2019041121452229800_B45","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041121452229800_B46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/cen.12986","article-title":"Influence of race\/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study","volume":"85","author":"Chang","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2019041121452229800_B47","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2265.2010.03873.x","article-title":"Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark","volume":"73","author":"Glintborg","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2019041121452229800_B48","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.fertnstert.2009.03.062","article-title":"Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance","volume":"94","author":"Cupisti","year":"2010","journal-title":"Fertil Steril"},{"issue":"3","key":"2019041121452229800_B49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/09513590.2011.589926","article-title":"Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 white patients with polycystic ovary syndrome","volume":"28","author":"Glintborg","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"2019041121452229800_B50","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/09513590.2013.788634","article-title":"Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome","volume":"29","author":"Pau","year":"2013","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"2019041121452229800_B51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/09513590.2015.1101440","article-title":"The amount and duration of smoking is associated with aggravation of hormone and biochemical profile in women with PCOS","volume":"32","author":"Xirofotos","year":"2016","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"2019041121452229800_B52","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1210\/jc.2015-1178","article-title":"Impact of male and female weight, smoking, and intercourse frequency on live birth in women with polycystic ovary syndrome","volume":"100","author":"Polotsky","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041121452229800_B53","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/09513590.2010.501876","article-title":"Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome","volume":"27","author":"Moradi","year":"2011","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"2019041121452229800_B54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/09513590.2011.613967","article-title":"High sensitivity C-reactive protein and its relationship with impaired glucose regulation in lean patients with polycystic ovary syndrome","volume":"28","author":"Kim","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"2019041121452229800_B55","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.2008-2406","article-title":"Sex differences in the relationship between C-reactive protein and body fat","volume":"94","author":"Khera","year":"2009","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/1\/12\/1417\/21840053\/js.2017-00323.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T11:14:03Z","timestamp":1555067643000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/1\/12\/1417\/4587526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,2]]},"references-count":55,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,11,2]]},"published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/js.2017-00323","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12,1]]},"published":{"date-parts":[[2017,11,2]]}}}